NextCure, Inc.

NextCure, Inc.verified

NXTC

Price:

$12.73

Market Cap:

$34.11M

NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4; and NC525, a novel LAIR-1 antibody which is in Preclinical...[Read more]

Industry

Biotechnology

IPO Date

2019-05-09

Stock Exchange

NASDAQ

Ticker

NXTC

The Enterprise Value as of December 2025 (TTM) for NextCure, Inc. (NXTC) is 33.89M

According to NextCure, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 33.89M. This represents a change of 418.07% compared to the average of 6.54M of the last 4 quarters.

NextCure, Inc. (NXTC) Historical Enterprise Value (quarterly & annually)

How has NXTC Enterprise Value performed in the past?

The mean historical Enterprise Value of NextCure, Inc. over the last ten years is 260.75M. The current 33.89M Enterprise Value has changed 1.20% with respect to the historical average. Over the past ten years (40 quarters), NXTC's Enterprise Value was at its highest in in the December 2018 quarter at 2.26B. The Enterprise Value was at its lowest in in the March 2025 quarter at -2541793.60.

Quarterly (TTM)
Annual

Average

260.75M

Median

212.08M

Minimum

-221929.50

Maximum

855.17M

NextCure, Inc. (NXTC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of NextCure, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 169.40%

Maximum Annual Enterprise Value = 855.17M

Minimum Annual Increase = -100.88%

Minimum Annual Enterprise Value = -221929.50

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024-221929.50-100.88%
202325.26M28.78%
202219.61M-87.21%
2021153.36M-43.37%
2020270.80M-68.33%
2019855.17M169.40%
2018317.44M-28.60%

NextCure, Inc. (NXTC) Average Enterprise Value

How has NXTC Enterprise Value performed in the past?

The current Enterprise Value of NextCure, Inc. (NXTC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.88M

5-year avg

93.76M

10-year avg

260.75M

NextCure, Inc. (NXTC) Enterprise Value vs. Peers

How is NXTC’s Enterprise Value compared to its peers?

NextCure, Inc.’s Enterprise Value is greater than Q32 Bio Inc. (6.85M), greater than Plus Therapeutics, Inc. (26.35M), less than Boundless Bio, Inc. (59.44M), less than Verrica Pharmaceuticals Inc. (72.93M), greater than AN2 Therapeutics, Inc. (10.96M), greater than Jasper Therapeutics, Inc. (-7125220.00), greater than Intensity Therapeutics, Inc. (14.75M), less than Pluri Inc. (46.18M), greater than TAO Synergies Inc. (8.89M), greater than Iterum Therapeutics plc (10.14M),

Build a custom stock screener for NextCure, Inc. (NXTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NextCure, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NextCure, Inc. (NXTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NextCure, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is NextCure, Inc.'s Enterprise Value?

What is the highest Enterprise Value for NextCure, Inc. (NXTC)?

What is the 3-year average Enterprise Value for NextCure, Inc. (NXTC)?

What is the 5-year average Enterprise Value for NextCure, Inc. (NXTC)?

How does the current Enterprise Value for NextCure, Inc. (NXTC) compare to its historical average?